News

#

Eye-Tracking and Stroke

A stroke is a life-changing event that can have long-lasting impact on the quality of life of an individual. Up to two-thirds of patients with unilateral brain injury suffer from neglect, defined as the inability to report, respond, or orient to novel or meaningful stimuli presented to the side opposite to the brain lesion. The […]

READ MORE
#

Eye-tracking as a potential biomarker for autism

The Autism Biomarkers Consortium for Clinical Trials is a multisite study specifically designed to evaluate a set of promising electrophysiological and eye-tracking (ET) methodologies as candidate biomarkers for autism spectrum disorder (ASD). ET task uses pupillary reflex measurements and gaze monitoring under different visual tasks, to identify specific features associated with ASD. Two recent publications […]

READ MORE
#

Improving eye vergence function in persons with Parkinson’s disease

Eye-tracking tools can support clinicians in the management of Parkinson’s Disease (PD) patients. Over 30 years of research has shown that PD profoundly impacts the control of eye movements. These include: pupil reactivity, smooth pursuit, saccadic movements, optokinetic response, and vergence [1-3]. Recently, research examining the ability to improve vergence eye impairments and related symptoms. […]

READ MORE
#

Saccadic intrusions in paediatric concussion – is there a link to academic performance?

A recent case report study identified saccadic intrusions present only during smooth pursuit and not during fixation, in children 10 to 15 years old who suffered a concussion. Saccadic instructions are involuntary conjugate saccades that interrupt fixation, a common symptom post mTBI. The study concluded that Gabapentin treatment reduced the magnitude of saccadic intrusions and […]

READ MORE
#

Do concussion related deficits in reaction time inform return to activity?

Numerous studies report deficits in reaction time following a concussion, including published research using Neurolign Dx platform devices [1,2]. The recovery time course of reaction time deficits was recently reviewed in “Examination of Reaction Time Deficits Following Concussion: A Systematic Review and Meta-analysis”

READ MORE
#

Presenting at the American Balance Society Annual Meeting March 2020

Join us March 3-4, 2020 in Scottsdale for the American Balance Society Annual Meeting. Explore cutting-edge research and partake in collaborative sessions discussing case studies.

READ MORE
#

Research Leveraging Neurolign published in Race Car Engineer

Neurolign’s Dx 100™ (formerly I-PAS) is leveraged by University of Cambridge researchers in collaboration with the world governing body for motorsport, the FIA [Federation Internationale de l’Automobile], and the FIA Foundation in their first prospective concussion research programme.

READ MORE
#

Neurolign Technologies Inc. to Present at Biotech Showcase™ 2020 in San Fransisco

Neurolign presenting company overview at BioTech Showcase

Toronto, ON, January 8, 2020 – Neurolign Technologies Inc. (“Neurolign”) has scheduled company presentations at Biotech Showcase™ 2020, to be held January 13–15, a critical event for healthcare innovation and investment at the Hilton San Francisco Union Square.

READ MORE
#

Neurolign Technologies Inc. Acquires Neuro Kinetics Inc.

On September 20th, 2019, Neurolign Technologies Inc. (“Neurolign”), announced the acquisition of Neuro Kinetics Inc. (“NKI”) of Pittsburgh, Pennsylvania. Neuro Kinetics Inc. is a leader in its field, providing eye-tracking diagnostic platforms that deliver, leading edge, neuro-functional assessments and monitoring to identify more than 200 diseases and medical conditions (www.neuro-kinetics.com).

READ MORE